BioMed Realty And Bristol-Myers Squibb Sign Lease To Expand Relationship To 194,100 Square Feet At Woodside Technology Park In

 BioMed Realty And Bristol-Myers Squibb Sign Lease To Expand Relationship To
 194,100 Square Feet At Woodside Technology Park In Redwood City, California

Global BioPharmaceutical Leader Leases an Additional 61,000 Square Feet to
Grow Its Presence and Research Capabilities in the Bay Area

PR Newswire

SAN DIEGO, July 24, 2014

SAN DIEGO, July 24, 2014 /PRNewswire/ --BioMed Realty Trust, Inc. (NYSE: BMR)
today announced that Bristol-Myers Squibb (NYSE: BMY) has signed a ten-year
lease for approximately 61,000 square feet of additional laboratory and
office space at the company's Woodside Technology Park life science campus in
Redwood City, California. The Redwood City campus will serve as Bristol-Myers
Squibb's hub for discovering pioneering cancer therapies in the emerging field
of immunotherapy.

With this lease, Bristol-Myers Squibb will fully occupy two of the three
buildings at the campus totaling 194,100 square feet as the company continues
to further strengthen its presence in the Bay Area, and will provide
additional capacity to conduct biologics drug discovery research at Woodside
Technology Park. Currently, Bristol-Myers Squibb is leasing the entire 700
Bay Road building on the campus comprising approximately 133,100 square feet.
In addition to expanding Bristol-Myers' footprint at Woodside Technology Park,
the companies agreed to extend the term of the lease on the 700 Bay Road
building, previously expiring in December 2022, by an additional 30 months.

Alan D. Gold, BioMed Realty's Chairman and Chief Executive Officer, commented,
"We are proud to be expanding and extending our valued relationship with
Bristol-Myers Squibb, truly a giant in the life science industry. By listening
to what the company needed, our Bay Area team was able to deliver a creative
solution to meet Bristol-Myers Squibb's growing real estate needs that will
enable them to focus on their research and development of new products and
therapies to meet the needs of those suffering from serious diseases."

The Woodside Technology Park has three laboratory and office buildings which
encompass approximately 256,000 square feet in the heart of the Bay Area's
Peninsula life science and high-tech communities.

About BioMed Realty Trust

BioMed Realty, with its trusted expertise and valuable relationships, delivers
optimal real estate solutions for biotechnology and pharmaceutical companies,
scientific research institutions, government agencies and other entities
involved in the life science industry. BioMed Realty owns or has interests in
properties comprising approximately 17.2 million rentable square feet.
Additional information is available at Follow us on
Twitter @biomedrealty.

This press release contains forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995 based on current
expectations, forecasts and assumptions that involve risks and uncertainties
that could cause actual outcomes and results to differ materially. These risks
and uncertainties include, without limitation: general risks affecting the
real estate industry (including, without limitation, the inability to enter
into or renew leases, dependence on tenants' financial condition, and
competition from other developers, owners and operators of real estate);
adverse economic or real estate developments in the life science industry or
the company's target markets; risks associated with the availability and terms
of financing, the use of debt to fund acquisitions, developments and other
investments, and the ability to refinance indebtedness as it comes due;
failure to maintain the company's investment grade credit ratings with the
ratings agencies; failure to manage effectively the company's growth and
expansion into new markets, or to complete or integrate acquisitions and
developments successfully; reductions in asset valuations and related
impairment charges; risks and uncertainties affecting property development and
construction; risks associated with tax credits, grants and other subsidies to
fund development activities; risks associated with downturns in foreign,
domestic and local economies, changes in interest rates and foreign currency
exchange rates, and volatility in the securities markets; ownership of
properties outside of the United States that subject the company to different
and potentially greater risks than those associated with the company's
domestic operations; risks associated with the company's investments in loans,
including borrower defaults and potential principal losses; potential
liability for uninsured losses and environmental contamination; risks
associated with the company's potential failure to qualify as a REIT under the
Internal Revenue Code of 1986, as amended, and possible adverse changes in tax
and environmental laws; and risks associated with the company's dependence on
key personnel whose continued service is not guaranteed. For a further list
and description of such risks and uncertainties, see the reports filed by the
company with the Securities and Exchange Commission, including the company's
most recent annual report on Form 10-K and quarterly reports on Form 10-Q. The
company disclaims any intention or obligation to update or revise any
forward-looking statements, whether as a result of new information, future
events or otherwise.

SOURCE BioMed Realty Trust, Inc.

Contact: Rick Howe, Senior Director, Corporate Communications, 858.207.5859,
Press spacebar to pause and continue. Press esc to stop.